Effect of fish oil supplement on chronic atrial fibrillatio
Not Applicable
- Conditions
- Atrial fibrillation.Atrial fibrillation and flutter
- Registration Number
- IRCT2012110411362N1
- Lead Sponsor
- School of Public Health, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
postmenopausal women; men; above 50 years old; BMI higher than 25 kg/m2; patients without hyperthyroidism; patients without heart valve disorders; patients did not underwent coronary artery bypass surgery in the last three months; patients without heart failure of class IV; patients without history of alcohol abuse; not started taking in fish oil supplement within the three months before intervention; patients without allergy to fish oil
Exclusion criteria: patients who stops taking supplement or placebo; patients who lose interest in participating in the study; patient who undergo coronary bypass
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adiponectin. Timepoint: before intervention and 8 weeks after intervention. Method of measurement: µg/ml, elisa kit.;Asymmetric dimethylarginine (ADMA). Timepoint: before intervention and 8 weeks after intervention. Method of measurement: mol/Lµ, elisa kit.
- Secondary Outcome Measures
Name Time Method